1. Home
  2. INAB vs TIRX Comparison

INAB vs TIRX Comparison

Compare INAB & TIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • TIRX
  • Stock Information
  • Founded
  • INAB 2016
  • TIRX 2010
  • Country
  • INAB United States
  • TIRX China
  • Employees
  • INAB N/A
  • TIRX N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • TIRX Specialty Insurers
  • Sector
  • INAB Health Care
  • TIRX Finance
  • Exchange
  • INAB Nasdaq
  • TIRX Nasdaq
  • Market Cap
  • INAB 14.5M
  • TIRX 14.0M
  • IPO Year
  • INAB 2021
  • TIRX 2021
  • Fundamental
  • Price
  • INAB $2.17
  • TIRX $1.27
  • Analyst Decision
  • INAB Strong Buy
  • TIRX
  • Analyst Count
  • INAB 2
  • TIRX 0
  • Target Price
  • INAB $108.00
  • TIRX N/A
  • AVG Volume (30 Days)
  • INAB 383.7K
  • TIRX 1.2M
  • Earning Date
  • INAB 08-07-2025
  • TIRX 08-15-2025
  • Dividend Yield
  • INAB N/A
  • TIRX N/A
  • EPS Growth
  • INAB N/A
  • TIRX N/A
  • EPS
  • INAB N/A
  • TIRX N/A
  • Revenue
  • INAB N/A
  • TIRX $3,219,336.00
  • Revenue This Year
  • INAB N/A
  • TIRX N/A
  • Revenue Next Year
  • INAB N/A
  • TIRX N/A
  • P/E Ratio
  • INAB N/A
  • TIRX N/A
  • Revenue Growth
  • INAB N/A
  • TIRX 158.74
  • 52 Week Low
  • INAB $2.06
  • TIRX $1.07
  • 52 Week High
  • INAB $27.60
  • TIRX $4.15
  • Technical
  • Relative Strength Index (RSI)
  • INAB 27.49
  • TIRX 42.99
  • Support Level
  • INAB $2.06
  • TIRX $1.20
  • Resistance Level
  • INAB $2.31
  • TIRX $1.45
  • Average True Range (ATR)
  • INAB 0.31
  • TIRX 0.07
  • MACD
  • INAB -0.00
  • TIRX -0.01
  • Stochastic Oscillator
  • INAB 4.74
  • TIRX 29.63

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

Share on Social Networks: